Harpoon Therapeutics, Inc.
COMPOSITIONS AND METHODS FOR ADOPTIVE CELL THERAPIES
Last updated:
Abstract:
Provided herein are immune cells engineered to express one or more cell surface receptor polypeptides containing activatable antigen receptor polypeptides, and methods of use thereof for the treatment of diseases, including cancer.
Status:
Application
Type:
Utility
Filling date:
3 May 2018
Issue date:
16 Apr 2020